Belgium· BE-AMP-SAM086371-00

Strumazol 10 mg

A thiamazole product containing thiamazole, registered in Belgium by Orifarm Generics. The same ATC class is registered in 12 of our 19 countries.

ATC H03BB02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedStrumazol 10 mgATCH03BB02REGISTER NO.BE-AMP-SAM086371-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Thiamazole is registered in 12 of 19 countries.

Countries holding a registration under ATC H03BB02 (thiamazole), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 6 of them publish a price we can compare per daily dose

Thiamazole · ATC H03BB02

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Netherlands
  • Polandprice
  • Sweden
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of thiamazole costs, country by country.

Normalised to the WHO defined daily dose (10 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Thiamazole · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • FR France$0.12
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Thiamazole
Manufacturer
Orifarm Generics
Country
Belgium (BE)
ATC code
H03BB02
ATC class
Thiamazole
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

1 priced
  • be_apb
    0083725
    EUR 10.44
  • be_apb
    0718015

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

170 interactions on record for thiamazole.

Graded by severity as the source publishes them — 10 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Thiamazole · interactions on record

170 records

  • 10 severe
  • 42 moderate
  • 2 minor
  • 116 info

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • PexidartinibL01EX15severe
  • LeflunomidL04AA13severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Thiamazole in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All thiamazole products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

  • Austria · Thiamazol Sandoz
  • Bulgaria · Метизол, Тирозол
  • Cyprus · Unimazole
  • Czechia · Thyrozol
  • Germany · Methizol Sd, Thiamazol
  • Denmark · Thiamazole "uni-Pharma", Thycapzol
  • Estonia · Thyrozol
  • Spain · Tirodril
  • France · Thiamazole Uni-Pharma, Thyrozol
  • Greece · Unimazole
  • Croatia · Athyrazol
  • Hungary · Metothyrin
  • Iceland · Thiamazole Uni-Pharma
  • Italy · Tapazole
  • Lithuania · Metizol, Thyrozol
  • Luxembourg · Strumazol, Thyrozol
  • Latvia · Thyrozol
  • Netherlands · Strumazol
  • Poland · Metizol, Thyrozol
  • Portugal · Metibasol
  • Romania · Thyrozol
  • Sweden · Thacapzol, Thiamazole Uni-Pharma
  • Slovenia · Athyrazol
  • Slovakia · Thyrozol

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c65671b7-f7e1-486c-86f0-c2fa3c08c917
GET /v1/drugs/c65671b7-f7e1-486c-86f0-c2fa3c08c917?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Strumazol 10 mg",
  "name_fr": "Strumazol 10 mg",
  "name_nl": "Strumazol 10 mg",
  "amp_code": "SAM086371-00",
  "strengths": [
    "10.0000",
    "10.0000",
    "288.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Thiamazole",
    "Lactose Monohydrate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Thiamazole",
  "authorisation_numbers": [
    "BE086371"
  ]
}

See everything about thiamazole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.